• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATS 机械心脏瓣膜假体 15 年的经验。

Fifteen years of experience with ATS mechanical heart valve prostheses.

机构信息

Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan.

出版信息

J Thorac Cardiovasc Surg. 2010 Jun;139(6):1494-500. doi: 10.1016/j.jtcvs.2009.07.039. Epub 2009 Sep 10.

DOI:10.1016/j.jtcvs.2009.07.039
PMID:19744673
Abstract

BACKGROUND

ATS Medical, Inc, developed a mechanical heart valve that has been in use since 1992. In this article, we present the results of 15 years of follow-up of patients who have undergone ATS heart valve replacement at our hospital.

METHODS AND RESULTS

We performed ATS heart valve replacements on 231 patients between September 1993 and March 2008. Our operative mortality rate for the study period was 2.2%. The survival for postoperative thromboembolic events was 0.29%/pt-y for aortic valve replacement, 0.48%/pt-y for mitral, 0.80%/pt-y for double valve replacement, and overall 0.44%/pt-y. The survival after bleeding events was 0.29%/pt-y for aortic valve replacement, 0.16%/pt-y for mitral, 0%/pt-y for double valve replacement, and overall 0.19%/pt-y. Patient-prosthesis mismatch, as determined by echocardiography, was found in 83.3% of patients at 19 mm, but other sizes showed good valve function. Prosthetic valve noise was undetectable in 92.8% of patients, and quality of life was excellent.

CONCLUSIONS

Few prosthetic valve-related complications were seen with ATS heart valve replacements in this study, and the follow-up results were favorable. The international normalized ratio was maintained in the range 1.6 to 2.0 in patients with aortic valve replacement in sinus rhythm. Not only bleeding events, seen at a rate of 0.19%/pt-y, but also thromboembolic events, at 0.44%/pt-y, were low when compared with conventional mechanical valves. Prosthetic valve noise is low, and this appears to be an excellent mechanical valve from the quality of life standpoint. The ATS valve has an excellent safety profile when compared with other mechanical valves.

摘要

背景

ATS 医疗公司开发了一种机械心脏瓣膜,自 1992 年以来一直在使用。在本文中,我们介绍了在我们医院接受 ATS 心脏瓣膜置换术的患者 15 年随访的结果。

方法和结果

我们在 1993 年 9 月至 2008 年 3 月期间对 231 例患者进行了 ATS 心脏瓣膜置换术。研究期间我们的手术死亡率为 2.2%。术后血栓栓塞事件的生存率为主动脉瓣置换术为 0.29%/pt-y,二尖瓣置换术为 0.48%/pt-y,双瓣置换术为 0.80%/pt-y,总生存率为 0.44%/pt-y。出血事件后的生存率为主动脉瓣置换术为 0.29%/pt-y,二尖瓣置换术为 0.16%/pt-y,双瓣置换术为 0%/pt-y,总生存率为 0.19%/pt-y。超声心动图显示,83.3%的患者存在 19mm 的患者-假体不匹配,但其他尺寸显示出良好的瓣膜功能。92.8%的患者听不到人工瓣膜噪音,生活质量极好。

结论

在这项研究中,ATS 心脏瓣膜置换术的患者出现的人工瓣膜相关并发症较少,随访结果良好。在窦性心律的主动脉瓣置换术中,国际标准化比值维持在 1.6 至 2.0 之间。与传统的机械瓣膜相比,不仅出血事件的发生率为 0.19%/pt-y,血栓栓塞事件的发生率为 0.44%/pt-y 也较低。人工瓣膜噪音低,从生活质量的角度来看,这似乎是一种极好的机械瓣膜。与其他机械瓣膜相比,ATS 瓣膜具有极佳的安全性。

相似文献

1
Fifteen years of experience with ATS mechanical heart valve prostheses.ATS 机械心脏瓣膜假体 15 年的经验。
J Thorac Cardiovasc Surg. 2010 Jun;139(6):1494-500. doi: 10.1016/j.jtcvs.2009.07.039. Epub 2009 Sep 10.
2
Five-year follow up of the ATS mechanical heart valve.美国胸科学会(ATS)机械心脏瓣膜的五年随访
J Heart Valve Dis. 2004 Mar;13(2):231-8.
3
Single-center outcome analysis of 1,161 patients with St. Jude medical and ATS open pivot mechanical heart valves.1161例植入圣犹达医疗公司和ATS开放式枢轴机械心脏瓣膜患者的单中心结局分析。
J Heart Valve Dis. 2007 Mar;16(2):151-8.
4
Simultaneous implantation of St. Jude Medical aortic and mitral prostheses.同时植入圣犹达医疗公司的主动脉和二尖瓣假体。
J Thorac Cardiovasc Surg. 1987 Nov;94(5):733-9.
5
[Replacement of the mitral and aortic valves with bioprostheses. Long-term results].[生物人工瓣膜置换二尖瓣和主动脉瓣。长期结果]
G Ital Cardiol. 1985 Oct;15(10):974-82.
6
Nine-year routine clinical experience of aortic valve replacement with ATS mechanical valves.使用ATS机械瓣膜进行主动脉瓣置换术的九年常规临床经验。
J Heart Valve Dis. 2008 Nov;17(6):648-56.
7
Heart valve replacement with the Sorin tilting-disc prosthesis. A 10-year experience.使用索林倾斜盘式人工心脏瓣膜进行心脏瓣膜置换术。十年经验。
J Thorac Cardiovasc Surg. 1992 Feb;103(2):267-75.
8
Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve.关于ATS开放枢轴双叶心脏瓣膜的11年单中心经验。
Ann Thorac Surg. 2006 Sep;82(3):847-52. doi: 10.1016/j.athoracsur.2006.04.042.
9
Combined mitral and aortic valve replacement for rheumatic heart disease: fifteen-year follow up and long-term results.风湿性心脏病二尖瓣与主动脉瓣联合置换术:15年随访及长期结果
J Heart Valve Dis. 2009 Mar;18(2):170-9.
10
Four years' experience with the Edwards-Tekna bileaflet valve prosthesis.使用爱德华兹-泰克纳双叶瓣人工心脏瓣膜的四年经验。
J Heart Valve Dis. 2002 Mar;11(2):263-9.

引用本文的文献

1
Comparison of a novel mechanical valve versus stented bioprosthetic valves for isolated mitral valve replacement in patients older than 65 years.新型机械瓣膜与带支架生物瓣膜用于65岁以上患者单纯二尖瓣置换术的比较
JTCVS Open. 2025 Jun 26;26:85-93. doi: 10.1016/j.xjon.2025.06.015. eCollection 2025 Aug.
2
Prosthetic Heart Valves: More than Half a Century of Innovation-An Overview.人工心脏瓣膜:半个多世纪的创新——综述
J Clin Med. 2025 May 16;14(10):3499. doi: 10.3390/jcm14103499.
3
Thirty-year outcomes of low-intensity anticoagulation for mechanical aortic valve.
机械主动脉瓣低强度抗凝 30 年结果。
Heart Vessels. 2024 Jun;39(6):549-555. doi: 10.1007/s00380-024-02365-x. Epub 2024 Feb 23.
4
Design, Manufacturing Technology and In-Vitro Evaluation of Original, Polyurethane, Petal Valves for Application in Pulsating Ventricular Assist Devices.用于脉动式心室辅助装置的原创聚氨酯花瓣阀的设计、制造技术及体外评估
Polymers (Basel). 2020 Dec 15;12(12):2986. doi: 10.3390/polym12122986.
5
Nineteen Years of Single Institute Experiences with Sorin Bicarbon Prosthesis.索林碳酸氢盐假体的单机构19年经验
Ann Thorac Cardiovasc Surg. 2019 Aug 20;25(4):192-199. doi: 10.5761/atcs.oa.18-00223. Epub 2019 Mar 12.
6
Thoracoscope-Assisted Mitral Valve Replacement with a Small Incision in the Right Chest: A Chinese Single Cardiac Center Experience.胸腔镜辅助右胸小切口二尖瓣置换术:中国单中心经验。
Med Sci Monit. 2018 Feb 20;24:1054-1063. doi: 10.12659/msm.905855.
7
Fifteen-year experience with the Bicarbon heart valve prosthesis in a single center.在单一中心使用碳酸氢盐心脏瓣膜假体的十五年经验。
J Cardiothorac Surg. 2015 Jun 28;10:89. doi: 10.1186/s13019-015-0294-x.
8
Selection of prosthetic valve and evidence--need for the development of Japan's own guidelines.人工心脏瓣膜的选择与证据——日本制定本国指南的必要性
Ann Thorac Cardiovasc Surg. 2015;21(4):305-13. doi: 10.5761/atcs.ra.15-00134. Epub 2015 Jun 9.
9
Long-Term Outcome of Prosthetic Valve Replacement in Japanese Patients Aged 65 Years or Older: Are Guidelines for Prosthetic Valve Selection Based on Overseas Data Appropriate for Japanese Patients?65岁及以上日本患者人工瓣膜置换术的长期结果:基于海外数据的人工瓣膜选择指南对日本患者是否适用?
Ann Thorac Cardiovasc Surg. 2015;21(3):254-60. doi: 10.5761/atcs.oa.15-00062. Epub 2015 May 25.
10
Valve-related complications after mechanical heart valve implantation.机械心脏瓣膜植入术后与瓣膜相关的并发症。
Surg Today. 2015 Oct;45(10):1205-9. doi: 10.1007/s00595-014-1104-0. Epub 2014 Dec 18.